Surgical management of macular holes: A report by the American Academy of Ophthalmology

Ophthalmology

Volumn 108, Issue 7, 2001, Pages 1328-1335

  Benson, William E ^a   Cruickshanks, Karen C ^a   Fong, Donald S ^a   Williams, George A ^a   Bloome, Michael A ^a   Frambach, Donald Allen ^a   Kreiger, Allan E ^a   Murphy, Robert P ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CATARACT; CLINICAL FEATURE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DISEASE COURSE; ENDOPHTHALMITIS; HUMAN; MEDICAL LITERATURE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA HOLE; RISK ASSESSMENT; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0034967206     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(01)00731-X     Document Type: Review

References (52)

1. Idiopathic senile macular hole. Its early stages and pathogenesis
2. Reappraisal of biomicroscopic classification of stages of development of a macular hole
3. Optical coherence tomography of macular holes
4. Macular hole formation: New data provided by optical coherence tomography
5. Foveal pseudocyst as the first step in macular hole formation: A prospective study by optical coherence tomography
6. Dome-shaped detachment of premacular vitreous cortex in macular hole development
7. Vitreous surgery for idiopathic macular holes. Results of a pilot study
8. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial
9. Vitrectomy for prevention of macular holes. Results of a randomized multicenter clinical trial
10. Prospective randomized trial of vitrectomy or observation for stage 2 macular holes
11. Transforming growth factor-beta 2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes. Preliminary anatomic results of a multicenter prospective randomized study
12. Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery
13. Effect of autologous platelet concentrate in surgery for idiopathic macular hole: Results of a multicenter, double-masked, randomized trial
14. Bilateral visual function after macular hole surgery
15. Visual function and patient satisfaction after macular hole surgery
16. Macular hole surgery with internal-limiting membrane peeling and intravitreous air
17. Surgical management of macular holes: Results using gas tamponade alone, or in combination with autologous platelet concentrate, or transforming growth factor beta 2
18. Autologous platelet concentrate in the surgical management of macular holes
19. Distribution of iatrogenic retinal breaks in macular hole surgery
20. Posterior segment complications after vitrectomy for macular hole
21. Vision-threatening complications of surgery for full-thickness macular holes
22. Progression of nuclear sclerosis and long-term visual results of vitrectomy with transforming growth factor beta-2 for macular holes
23. Long-term visual outcomes in patients with successful macular hole surgery
24. Macular hole surgery without face-down positioning. A pilot study
25. Macular hole surgery using thrombin-activated fibrinogen and selective removal of the internal limiting membrane
26. Late re-opening of macular holes after initially successful treatment with vitreous surgery
27. Long-term incidence of reopening of macular holes
28. Reopening of macular holes after initially successful repair
29. Internal limiting membrane removal in the management of full-thickness macular holes
30. The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness macular holes
31. Use of autologous platelet concentrate in macular hole surgery: Report of 77 cases
32. Macular hole surgery without using adjunctive additives
33. Effect of perifoveal tissue dissection in the management of acute idiopathic full-thickness macular holes
34. Macular hole surgery with and without internal limiting membrane peeling
35. The macular hole: Report of an Australian surgical series and meta-analysis of the literature
36. Incidence of idiopathic full-thickness macular holes in fellow eyes. A 5-year prospective natural history study
37. Bilaterality of idiopathic macular holes
38. A multicentered clinical study of serum as adjuvant therapy for surgical treatment of macular holes
39. Macular hole surgery. Comparison of longstanding versus recent macular holes
40. Results of surgical treatment of recent-onset full-thickness idiopathic macular holes
41. Closure of persistent macular holes with human recombinant transforming growth factor-beta 2
42. Success with macular hole surgery
43. Human autologous serum for the treatment of full-thickness macular holes. A preliminary study
44. Surgical treatment of full-thickness macular holes using autologous serum
45. Treatment of full-thickness macular holes with autologous serum
46. Surgical closure of macular hole using an absorbable macular plug
47. Thrombin in the management of full thickness macular holes
48. Plasmin enzyme-assisted vitrectomy in traumatic pediatric macular holes
49. Diamond-dusted silicone cannula for epiretinal membrane separation during vitreous surgery
50. Intraocular tamponade duration and success of macular hole surgery
51. Silicone oil tamponade to seal macular holes without position restrictions
52. Silicone oil vs. gas for the treatment of full-thickness macular hole